Genetic modulation of the pathway linking PLK1 to APC/C activation curtailed the proliferation of mutant KRAS G12D-expressing cancer cells, while ATP-competitive PLK1 inhibitors suppressed their growth as xenografts. This evidence concerns the gene APC and cancer.